Multiple Sclerosis
"Multiple Sclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Descriptor ID |
D009103
|
MeSH Number(s) |
C10.114.375.500 C10.314.350.500 C20.111.258.250.500
|
Concept/Terms |
Multiple Sclerosis- Multiple Sclerosis
- Sclerosis, Multiple
- Sclerosis, Disseminated
- Disseminated Sclerosis
- MS (Multiple Sclerosis)
|
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis".
This graph shows the total number of publications written about "Multiple Sclerosis" by people in this website by year, and whether "Multiple Sclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 | 1998 | 1 | 0 | 1 | 2002 | 2 | 0 | 2 | 2003 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 | 2023 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Multiple Sclerosis" by people in Profiles.
-
Bruce JM, Cozart JS, Shook RP, Befort C, Siengsukon CF, Simon S, Lynch SG, Mahmoud R, Drees B, Posson P, Hibbing PR, Huebner J, Bradish T, Robichaud J, Bruce AS. Modifying diet and exercise in multiple sclerosis (MoDEMS): A randomized controlled trial for behavioral weight loss in adults with multiple sclerosis and obesity. Mult Scler. 2023 Dec; 29(14):1860-1871.
-
Pradeep Kumar D, Zanotto T, Cozart JS, Bruce AS, Befort C, Siengsukon C, Shook R, Lynch S, Mahmoud R, Simon S, Hibbing PR, Drees B, Huebner J, Bradish T, Robichaud J, Sosnoff JJ, Bruce JM. Association between frailty and sleep quality in people living with multiple sclerosis and obesity: An observational cross-sectional study. Mult Scler Relat Disord. 2024 Jan; 81:105154.
-
Cozart JS, Bruce AS, Shook RP, Befort C, Siengsukon C, Simon S, Lynch SG, Mahmoud R, Drees B, Posson P, Hibbing PR, Huebner J, Bradish T, Robichaud J, Bruce JM. Body metrics are associated with clinical, free-living, and self-report measures of mobility in a cohort of adults with obesity and multiple sclerosis. Mult Scler Relat Disord. 2023 Nov; 79:105010.
-
Bruce JM, Cozart JS, Shook RP, Ruppen S, Siengsukon C, Simon S, Befort C, Lynch S, Mahmoud R, Drees B, Norouzinia AN, Bradish T, Posson P, Hibbing PR, Bruce AS. Modifying Diet and Exercise in MS (MoDEMS): Study design and protocol for a telehealth weight loss intervention for adults with obesity & Multiple Sclerosis. Contemp Clin Trials. 2021 08; 107:106495.
-
Bruce JM, Jarmolowicz DP, Lynch S, Thelen J, Lim SL, Smith J, Catley D, Bruce AS. How patients with multiple sclerosis weigh treatment risks and benefits. Health Psychol. 2018 07; 37(7):680-690.
-
Jarmolowicz DP, Bruce AS, Glusman M, Lim SL, Lynch S, Thelen J, Catley D, Zieber N, Reed DD, Bruce JM. On how patients with multiple sclerosis weigh side effect severity and treatment efficacy when making treatment decisions. Exp Clin Psychopharmacol. 2017 12; 25(6):479-484.
-
Thelen J, Bruce A, Catley D, Lynch S, Goggin K, Bradley-Ewing A, Glusman M, Norouzinia A, Strober L, Bruce J. Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention. J Behav Med. 2018 04; 41(2):253-260.
-
Jarmolowicz DP, Reed DD, Bruce AS, Catley D, Lynch S, Goggin K, Lim SL, Strober L, Glusman M, Norouzinia AN, Bruce JM. Using EP50 to forecast treatment adherence in individuals with multiple sclerosis. Behav Processes. 2016 Nov; 132:94-99.
-
Bruce JM, Bruce AS, Catley D, Lynch S, Goggin K, Reed D, Lim SL, Strober L, Glusman M, Ness AR, Jarmolowicz DP. Being Kind to Your Future Self: Probability Discounting of Health Decision-Making. Ann Behav Med. 2016 Apr; 50(2):297-309.
-
Tabansky I, Messina MD, Bangeranye C, Goldstein J, Blitz-Shabbir KM, Machado S, Jeganathan V, Wright P, Najjar S, Cao Y, Sands W, Keskin DB, Stern JN. Advancing drug delivery systems for the treatment of multiple sclerosis. Immunol Res. 2015 Dec; 63(1-3):58-69.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|